Vireo Growth (VREOF) Current Leases (2020 - 2026)
Vireo Growth's (VREOF) quarterly Current Leases came in at $6.1 million in Q1 2026, up 430.9% year-on-year from $1.1 million in Q1 2025, and up 69.44% quarter-over-quarter from $3.6 million in Q4 2025.
Vireo Growth (VREOF) Current Leases (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Current Leases across 7 years of filings, most recently posting $6.1 million for Q1 2026.
- Current Leases for Q1 2026 came in at $6.1 million, up 430.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.1 million (up 430.9% YoY), and the FY2025 annual result was $3.6 million, up 157.14% from the prior year.
- Current Leases came in at $6.1 million for Q1 2026 at Vireo Growth, up from $3.6 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $6.1 million in Q1 2026 to a low of $882457.0 in Q1 2024.
- The 5-year median for Current Leases is $1.4 million (2024), against an average of $2.1 million.
- Across the five-year window, Current Leases tumbled 49.97% in 2023 and surged 430.9% in 2026, its largest moves.
- Vireo Growth's Current Leases stood at $1.7 million in 2022, then tumbled by 47.03% to $890013.0 in 2023, then surged by 57.3% to $1.4 million in 2024, then jumped by 157.14% to $3.6 million in 2025, then jumped by 69.44% to $6.1 million in 2026.
- The last three Current Leases figures came in at $6.1 million (Q1 2026), $3.6 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 23.81 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 7.58 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 5.58 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Vireo Growth | - | - | 59.30 Mn | 6.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.10 Mn |
| Dec 31, 2025 | 3.60 Mn |
| Sep 30, 2025 | 4.77 Mn |
| Jun 30, 2025 | 4.35 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 953,389.00 |
| Mar 31, 2024 | 882,457.00 |
| Dec 31, 2023 | 890,013.00 |
| Sep 30, 2023 | 907,998.00 |
| Jun 30, 2023 | 888,327.00 |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 1.68 Mn |
| Sep 30, 2022 | 1.71 Mn |
| Jun 30, 2022 | 1.78 Mn |
| Mar 31, 2022 | 1.70 Mn |
| Dec 31, 2021 | 1.60 Mn |
| Sep 30, 2021 | 1.40 Mn |
| Jun 30, 2021 | 1.28 Mn |